CTSO (Cytosorbents Corp.) Stock Analysis - Hedge Fund Holdings
Cytosorbents Corp. (CTSO) is a publicly traded Healthcare sector company. As of May 21, 2026, CTSO trades at $0.47 with a market cap of $30.08M and a P/E ratio of -2.41. CTSO moved +0.00% today. Year to date, CTSO is -29.44%; over the trailing twelve months it is -44.08%. Its 52-week range spans $0.45 to $1.61. Analyst consensus is neutral with an average price target of $0.75. Rallies surfaces CTSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CTSO stock?
Hedge funds tracked by Rallies that own CTSO include Redmile Group. The latest tracked quarter is Mar 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cytosorbents Corp..
CTSO Key Metrics
Key financial metrics for CTSO
Metric
Value
Price
$0.47
Market Cap
$30.08M
P/E Ratio
-2.41
EPS
$-0.19
Dividend Yield
0.00%
52-Week High
$1.61
52-Week Low
$0.45
Volume
0
Avg Volume
0
Revenue (TTM)
$37.20M
Net Income
$-11.85M
Gross Margin
71.00%
Top Hedge Funds Holding CTSO
Redmile Group holds 181.64K shares of CTSO, changed +0.00% as of Mar 31, 2023.
Hedge funds tracked by Rallies that own CTSO include Redmile Group. The latest tracked quarter is Mar 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cytosorbents Corp..
Does Rallies show 13F holders for CTSO?
Yes. Rallies tracks hedge fund and 13F ownership data for CTSO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CTSO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CTSO. It does not provide personalized investment advice.